financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Biodexa Says Data Show Longevity of Effect of Potential Precancerous Polyps Treatment -- Shares Soar
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Biodexa Says Data Show Longevity of Effect of Potential Precancerous Polyps Treatment -- Shares Soar
Jul 11, 2024 7:09 AM

09:45 AM EDT, 07/11/2024 (MT Newswires) -- Biodexa Pharmaceuticals ( BDRX ) said Thursday that 12-month data from a mid-stage clinical trial showed the longevity of effect of eRapa in the treatment of precancerous polyps in the gastrointestinal tract.

The company said that based on the data, eRapa showed an overall 17% median decrease in overall polyp burden and non-progression rate of 75%.

Biodexa said that in one group, 89% of patients were considered non-progressors at 12 months, with a 29% median reduction in polyp burden.

The company said that a person with the condition will have a 100% chance of developing colorectal cancer if left untreated.

Shares of Biodexa jumped 101% in recent Thursday trading.

Price: 1.29, Change: +0.58, Percent Change: +81.41

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Parsons Wins $13 Million Task Order for Indo-Pacific Counter-Nuclear Smuggling System Deployment
Parsons Wins $13 Million Task Order for Indo-Pacific Counter-Nuclear Smuggling System Deployment
Sep 17, 2025
07:02 AM EDT, 09/17/2025 (MT Newswires) -- Parsons (PSN) said Wednesday that it won a $13 million task order to deliver end-to-end support for counter-nuclear smuggling systems to countries in the Indo-Pacific region. The company said the task order was awarded under the US National Nuclear Security Administration's Counter Nuclear Smuggling System Deployment multiple award task order contract. It covers...
 Manchester United posts sixth year of net loss, forecasts revenue dip
Manchester United posts sixth year of net loss, forecasts revenue dip
Sep 17, 2025
Sept 17 (Reuters) - Manchester United ( MANU ) reported an annual net loss for the sixth consecutive year on Wednesday and forecast lower revenue for the fiscal year, highlighting the club's ongoing financial struggles. The Premier League side posted a 33 million-pound ($45 million) loss for the year ended June 30, an improvement on the previous year's 113.2 million-pound...
 Regeneron's genetic disorder treatment meets main goal of late-stage trial
Regeneron's genetic disorder treatment meets main goal of late-stage trial
Sep 17, 2025
Sept 17 (Reuters) - Regeneron Pharmaceuticals ( REGN ) said on Wednesday its experimental treatment for patients with a rare genetic disorder affecting mobility has met the main goal of a late-stage trial. ...
 General Mills beats quarterly sales estimates, maintains annual forecasts
General Mills beats quarterly sales estimates, maintains annual forecasts
Sep 17, 2025
General Mills ( GIS ) beat quarterly sales estimates on Wednesday, as price cuts taken in past on select products lifted demand. However, the company said that category growth will likely be below its long-term targets amid a challenging consumer backdrop. The Cheerios maker maintained its annual sales and profit forecasts. The company expects full-year adjusted profit to decline by...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved